PortfoliosLab logo
ARQT vs. QCOM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ARQT and QCOM is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Performance

ARQT vs. QCOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcutis Biotherapeutics, Inc. (ARQT) and QUALCOMM Incorporated (QCOM). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
-32.48%
93.83%
ARQT
QCOM

Key characteristics

Sharpe Ratio

ARQT:

0.88

QCOM:

-0.14

Sortino Ratio

ARQT:

1.71

QCOM:

0.10

Omega Ratio

ARQT:

1.19

QCOM:

1.01

Calmar Ratio

ARQT:

0.80

QCOM:

-0.14

Martin Ratio

ARQT:

5.00

QCOM:

-0.25

Ulcer Index

ARQT:

12.93%

QCOM:

24.72%

Daily Std Dev

ARQT:

73.54%

QCOM:

43.56%

Max Drawdown

ARQT:

-95.02%

QCOM:

-86.75%

Current Drawdown

ARQT:

-60.19%

QCOM:

-34.15%

Fundamentals

Market Cap

ARQT:

$1.71B

QCOM:

$162.81B

EPS

ARQT:

-$1.16

QCOM:

$9.27

PS Ratio

ARQT:

8.72

QCOM:

4.00

PB Ratio

ARQT:

10.41

QCOM:

5.78

Total Revenue (TTM)

ARQT:

$146.97M

QCOM:

$31.31B

Gross Profit (TTM)

ARQT:

$131.10M

QCOM:

$17.50B

EBITDA (TTM)

ARQT:

-$82.41M

QCOM:

$10.16B

Returns By Period

In the year-to-date period, ARQT achieves a 5.67% return, which is significantly higher than QCOM's -3.66% return.


ARQT

YTD

5.67%

1M

-13.97%

6M

75.03%

1Y

68.23%

5Y*

-13.08%

10Y*

N/A

QCOM

YTD

-3.66%

1M

-8.08%

6M

-11.49%

1Y

-8.23%

5Y*

16.68%

10Y*

11.04%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARQT vs. QCOM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARQT
The Risk-Adjusted Performance Rank of ARQT is 8282
Overall Rank
The Sharpe Ratio Rank of ARQT is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of ARQT is 8282
Sortino Ratio Rank
The Omega Ratio Rank of ARQT is 7676
Omega Ratio Rank
The Calmar Ratio Rank of ARQT is 8181
Calmar Ratio Rank
The Martin Ratio Rank of ARQT is 8787
Martin Ratio Rank

QCOM
The Risk-Adjusted Performance Rank of QCOM is 4343
Overall Rank
The Sharpe Ratio Rank of QCOM is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of QCOM is 4040
Sortino Ratio Rank
The Omega Ratio Rank of QCOM is 4040
Omega Ratio Rank
The Calmar Ratio Rank of QCOM is 4343
Calmar Ratio Rank
The Martin Ratio Rank of QCOM is 4747
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ARQT vs. QCOM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and QUALCOMM Incorporated (QCOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ARQT, currently valued at 0.88, compared to the broader market-2.00-1.000.001.002.003.00
ARQT: 0.88
QCOM: -0.14
The chart of Sortino ratio for ARQT, currently valued at 1.71, compared to the broader market-6.00-4.00-2.000.002.004.00
ARQT: 1.71
QCOM: 0.10
The chart of Omega ratio for ARQT, currently valued at 1.19, compared to the broader market0.501.001.502.00
ARQT: 1.19
QCOM: 1.01
The chart of Calmar ratio for ARQT, currently valued at 0.80, compared to the broader market0.001.002.003.004.005.00
ARQT: 0.80
QCOM: -0.14
The chart of Martin ratio for ARQT, currently valued at 5.00, compared to the broader market-10.00-5.000.005.0010.0015.0020.00
ARQT: 5.00
QCOM: -0.25

The current ARQT Sharpe Ratio is 0.88, which is higher than the QCOM Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of ARQT and QCOM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.00NovemberDecember2025FebruaryMarchApril
0.88
-0.14
ARQT
QCOM

Dividends

ARQT vs. QCOM - Dividend Comparison

ARQT has not paid dividends to shareholders, while QCOM's dividend yield for the trailing twelve months is around 2.31%.


TTM20242023202220212020201920182017201620152014
ARQT
Arcutis Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QCOM
QUALCOMM Incorporated
2.31%2.18%2.18%2.67%1.47%1.69%2.81%4.27%3.50%3.17%3.72%2.17%

Drawdowns

ARQT vs. QCOM - Drawdown Comparison

The maximum ARQT drawdown since its inception was -95.02%, which is greater than QCOM's maximum drawdown of -86.75%. Use the drawdown chart below to compare losses from any high point for ARQT and QCOM. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-60.19%
-34.15%
ARQT
QCOM

Volatility

ARQT vs. QCOM - Volatility Comparison

Arcutis Biotherapeutics, Inc. (ARQT) and QUALCOMM Incorporated (QCOM) have volatilities of 23.90% and 22.87%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
23.90%
22.87%
ARQT
QCOM

Financials

ARQT vs. QCOM - Financials Comparison

This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and QUALCOMM Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items